Search clinical trials for: Selective Estrogen Receptor Modulator
Total 38725 results
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
Andrea DeCensiHerbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo di Oncologia and other collaboratorsNot yet recruiting
-
Medical College of WisconsinNot yet recruiting
-
Sohag UniversityNot yet recruitingDiffuse Large B Cell Lymphoma
-
International Research Training Group 2804German Research Foundation; Uppsala University; University Hospital TuebingenNot yet recruitingMenopause | Breast Cancer Female | Healthy Female | Anti-estrogenic TherapyGermany
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
University of NebraskaNot yet recruitingPancreatic Cyst | Pancreatic Mucinous Cystic NeoplasmUnited States
-
Region Örebro CountyMid-Sweden Regional Cancer Centre; Akademiska University Hospital, Uppsala,...Not yet recruiting
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical HyperplasiaUnited States
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Batterjee Medical CollegeNot yet recruiting
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
DR. DIANE CHISESI NFS. MD. PHD.IRBNot yet recruitingChronic Pain | Metastatic Breast Cancer | Tumor | Muscle NeoplasmsUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingDuctal Carcinoma in SituUnited States
-
Guangzhou University of Traditional Chinese MedicineUniversity of HoustonRecruitingXiao Chai Hu Tang | Irinotecan-induced DiarrheaChina
-
European Institute of OncologyIstituto Oncologico Veneto IRCCS; Ente Ospedaliero Ospedali Galliera; Istituto...Not yet recruitingDuctal Carcinoma in Situ | RAD51C Gene Mutation | RAD51D Gene Mutation | PALB2 Gene Mutation | Lobular Carcinoma in Situ | ATM Gene Mutation | CDH1 Gene Mutation | CHEK2 Gene Mutation | BRCA MutationItaly
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Canada, Poland, Portugal, United Kingdom, France, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Romania, ... and more
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Breast Atypical HyperplasiaUnited States
-
Fudan UniversityRecruiting
-
Tianjin Medical University Cancer Institute and...RecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
Neil ChappellNot yet recruitingInfertility | Infertility, FemaleUnited States
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer | Neoadjuvant Endocrine TherapyRussian Federation
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Bezmialem Vakif UniversityRecruiting
-
Sun Yat-sen UniversityNot yet recruiting
-
MedSIRRecruitingBreast Cancer | Breast Cancer, Early-OnsetSpain, France
-
Erasmus Medical CenterRecruitingER+ Breast CancerNetherlands
-
Eli Lilly and CompanyRecruitingBreast NeoplasmsChina, Japan, United States, Australia, Taiwan, Belgium, Canada, United Kingdom, Spain, France, Argentina, Ireland, Netherlands, Turkey, Czechia, Korea, Republic of, Finland, Hungary, Italy, Mexico, Brazil, Germany, India, Austria, Greece, Roman... and more
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
Jose Pablo LeoneEli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)RecruitingMale Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Negative Breast CarcinomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingQuality of Life | Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Breast CancerChina
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Sharif Medical Research CenterRecruitingMale Infertility | OligoasthenoteratozoospermiaPakistan
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Anthony Joshua, FRACPSt Vincent's Hospital, Sydney; Royal Prince Alfred Hospital, Sydney, Australia and other collaboratorsRecruitingOvarian CancerAustralia
-
Veronica Morgan JonesRecruitingBreast Cancer | Breast Carcinoma | HER2-negative Breast Cancer | Node-negative Breast CancerUnited States
-
National Institute of Oncology, HungaryNot yet recruiting
-
Umm Al-Qura UniversityNot yet recruitingPathologic Processes | Polycystic Ovary Syndrome | Vitamin D Deficiency | IVF | Vitamin D Supplement | Female Infertility
-
Stanford UniversityUnited States Department of DefenseRecruitingBreast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited States
-
Weill Medical College of Cornell UniversityRecruitingTestosterone DeficiencyUnited States
-
Ain Shams Maternity HospitalRecruitingPoor Response to Ovulation Induction Poseidon Type IVEgypt
-
Penn State UniversityThe John B. Pierce LaboratoryRecruitingEndometriosisUnited States
-
Mahmoud Ramadan mohamed ElkazzazMinistry of Health, Saudi ArabiaNot yet recruiting
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France